Edwards Lifesciences Return on Investment 2006-2019 | EW
Current and historical return on investment (ROI) values for Edwards Lifesciences (EW) over the last 10 years.
| Edwards Lifesciences ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2019-03-31 | $0.98B | $4.09B | 25.33% |
| 2018-12-31 | $0.96B | $3.73B | 25.43% |
| 2018-09-30 | $1.00B | $3.96B | 26.98% |
| 2018-06-30 | $0.97B | $3.76B | 25.78% |
| 2018-03-31 | $0.96B | $3.70B | 25.21% |
| 2017-12-31 | $1.02B | $3.40B | 26.87% |
| 2017-09-30 | $0.96B | $4.20B | 25.21% |
| 2017-06-30 | $0.92B | $3.96B | 25.88% |
| 2017-03-31 | $0.89B | $3.59B | 26.57% |
| 2016-12-31 | $0.78B | $3.44B | 24.64% |
| 2016-09-30 | $0.79B | $3.29B | 25.45% |
| 2016-06-30 | $0.75B | $3.07B | 24.72% |
| 2016-03-31 | $0.68B | $2.90B | 22.82% |
| 2015-12-31 | $0.64B | $3.10B | 21.74% |
| 2015-09-30 | $0.62B | $3.03B | 21.45% |
| 2015-06-30 | $0.59B | $2.89B | 21.26% |
| 2015-03-31 | $0.56B | $2.82B | 20.97% |
| 2014-12-31 | $0.49B | $2.79B | 19.70% |
| 2014-09-30 | $0.47B | $2.64B | 20.13% |
| 2014-06-30 | $0.45B | $2.51B | 20.58% |
| 2014-03-31 | $0.46B | $2.07B | 22.80% |
| 2013-12-31 | $0.47B | $2.14B | 24.57% |
| 2013-09-30 | $0.49B | $1.97B | 26.99% |
| 2013-06-30 | $0.48B | $1.81B | 27.36% |
| 2013-03-31 | $0.45B | $1.79B | 26.29% |
| 2012-12-31 | $0.42B | $1.67B | 25.57% |
| 2012-09-30 | $0.36B | $1.71B | 22.79% |
| 2012-06-30 | $0.33B | $1.62B | 21.20% |
| 2012-03-31 | $0.31B | $1.57B | 20.04% |
| 2011-12-31 | $0.30B | $1.49B | 26.21% |
| 2011-09-30 | $0.29B | $1.53B | 38.06% |
| 2011-06-30 | $0.30B | $1.56B | 77.18% |
| 2011-03-31 | $0.30B | 92.66% | |
| 2010-12-31 | $0.29B | 44.25% | |
| 2010-09-30 | $0.27B | 28.14% | |
| 2010-06-30 | $0.26B | $1.30B | 20.65% |
| 2010-03-31 | $0.25B | $1.28B | 20.50% |
| 2009-12-31 | $0.24B | $1.25B | 20.67% |
| 2009-09-30 | $0.23B | $1.19B | 20.86% |
| 2009-06-30 | $0.22B | $1.12B | 20.12% |
| 2009-03-31 | $0.21B | $1.07B | 19.45% |
| 2008-12-31 | $0.20B | $1.05B | 19.75% |
| 2008-09-30 | $0.19B | $1.08B | 19.30% |
| 2008-06-30 | $0.18B | $1.04B | 19.66% |
| 2008-03-31 | $0.18B | $0.84B | 20.07% |
| 2007-12-31 | $0.17B | $0.90B | 18.92% |
| 2007-09-30 | $0.17B | $0.89B | 18.37% |
| 2007-06-30 | $0.18B | $0.87B | 18.22% |
| 2007-03-31 | $0.17B | $1.01B | 17.50% |
| 2006-12-31 | $0.17B | $0.99B | 17.49% |
| 2006-09-30 | $0.18B | $0.98B | 17.70% |
| 2006-06-30 | $0.18B | $1.00B | 17.91% |
| 2006-03-31 | $0.18B | $1.01B | 18.24% |
| 2005-12-31 | $0.17B | $1.01B | 18.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $39.918B | $3.723B |
| Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $116.371B | 25.45 |
| Intuitive Surgical (ISRG) | United States | $60.755B | 55.98 |
| IDEXX Laboratories (IDXX) | United States | $24.457B | 64.16 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.130B | 15.85 |
| Teleflex (TFX) | United States | $15.428B | 33.43 |
| Olympus (OCPNY) | Japan | $15.394B | 115.18 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.496B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.404B | 38.83 |
| DexCom (DXCM) | United States | $13.582B | 266.38 |
| Hologic (HOLX) | United States | $12.684B | 20.40 |
| STERIS (STE) | Ireland | $12.512B | 30.26 |
| Varian Medical Systems (VAR) | United States | $12.266B | 31.29 |
| ABIOMED (ABMD) | United States | $11.895B | 72.37 |
| Masimo (MASI) | United States | $8.109B | 49.69 |
| Penumbra (PEN) | United States | $5.895B | 249.54 |
| SARTORIUS AG (SARTF) | Germany | $5.850B | 53.60 |
| Elekta AB (EKTAY) | Sweden | $5.096B | 38.40 |
| Integra LifeSciences Holdings (IART) | United States | $4.635B | 21.78 |
| Globus Medical (GMED) | United States | $4.093B | 25.52 |
| Tandem Diabetes Care (TNDM) | United States | $3.699B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.586B | 23.38 |
| Cantel Medical (CMD) | United States | $3.371B | 34.19 |
| Wright Medical Group (WMGI) | Netherlands | $3.366B | 667.25 |
| Glaukos (GKOS) | United States | $2.736B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.686B | 19.79 |
| Nihon Kohden (NHNKY) | Japan | $2.470B | 24.86 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.043B | 32.33 |
| Nevro (NVRO) | United States | $1.964B | 0.00 |
| Inogen (INGN) | United States | $1.375B | 30.43 |
| OPKO Health (OPK) | United States | $1.330B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.239B | 0.00 |
| Veracyte (VCYT) | United States | $1.138B | 0.00 |
| CryoLife (CRY) | United States | $1.112B | 110.30 |
| Accelerate Diagnostics (AXDX) | United States | $1.037B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.035B | 152.75 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.983B | 28.48 |
| Mesa Laboratories (MLAB) | United States | $0.938B | 44.13 |
| Pacific Biosciences Of California (PACB) | United States | $0.907B | 0.00 |
| Luminex (LMNX) | United States | $0.892B | 116.65 |
| ViewRay (VRAY) | United States | $0.889B | 0.00 |
| Natus Medical (BABY) | United States | $0.880B | 20.38 |
| AngioDynamics (ANGO) | United States | $0.807B | 26.44 |
| AxoGen (AXGN) | United States | $0.797B | 0.00 |
| Fluidigm (FLDM) | United States | $0.762B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.694B | 0.00 |
| Intersect ENT (XENT) | United States | $0.637B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.522B | 0.00 |
| Si-Bone (SIBN) | United States | $0.486B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.367B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.354B | 19.01 |
| Accuray (ARAY) | United States | $0.318B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.317B | 39.00 |
| Semler Scientific (SMLR) | United States | $0.289B | 57.37 |
| SeaSpine Holdings (SPNE) | United States | $0.249B | 0.00 |
| ConforMIS (CFMS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.204B | 0.00 |
| IRadimed (IRMD) | United States | $0.202B | 38.43 |
| Sientra (SIEN) | United States | $0.183B | 0.00 |
| Stereotaxis (STXS) | United States | $0.168B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.096B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.093B | 0.00 |
| Vermillion (VRML) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.070B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.067B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.067B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.067B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.055B | 0.00 |
